| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |